Format

Send to

Choose Destination
Ann Epidemiol. 2018 Dec;28(12):841-849. doi: 10.1016/j.annepidem.2018.06.005. Epub 2018 Jun 15.

The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Author information

1
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA. Electronic address: asiegle@emory.edu.
2
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA; Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC.
3
Pharmacovigilance & Epidemiology, Gilead Sciences, Foster City, CA.
4
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
5
Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, Washington, DC.
6
Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA.

Abstract

PURPOSE:

The number of individuals who have started a regimen for HIV pre-exposure prophylaxis (PrEP) in the United States is not well characterized but has been on the rise since 2012. This analysis assesses the distribution of PrEP use nationally and among subgroups.

METHODS:

A validated algorithm quantifying tenofovir disoproxil fumarate/emtricitabine for PrEP in the United States was applied to a national prescription database to determine the quarterly prevalence of PrEP use. HIV diagnoses from 2016 were used as an epidemiological proxy for PrEP need. The PrEP-to-need ratio (PnR) was defined as the number of PrEP users divided by new HIV diagnoses.

RESULTS:

A total of 70,395 individuals used PrEP in the fourth quarter of 2017: 67,166 males and 3229 females. Nationally, prevalence of PrEP use was 26/100,000 (range across states per 100,000 [RAS/100k]: 4-73) and the PnR was 1.8 (RAS: 0.5-6.6). Prevalence of PrEP use among males and females, respectively, was 50/100,000 and 2/100,000 (RAS/100k: 7-143 and 0.3-7) and PnR was 2.1 and 0.4 (RAS: 0.6-7.1 and 0.1-4.0). Prevalence of PrEP use was lowest among individuals aged less than or equal to 24 and more than or equal to 55 years (15/100,000 and 6/100,000, RAS/100k: 1-45 and 0.4-14), with PnR 0.9 and 1.5 (RAS: 0.2-5.6 and 0.3-7.0). The Northeast had the highest PnR (3.3); the South had the lowest (1.0). States with Medicaid expansion had more than double the PnR than states without expansion.

CONCLUSIONS:

Available data suggest that females, individuals aged less than or equal to 24 years and residents of the South had lower levels of PrEP use relative to epidemic need. These results are ecological, and misclassification may attenuate results. PnR is useful for future assessments of HIV prevention strategy uptake.

KEYWORDS:

HIV; Pre-exposure prophylaxis; Prevention

PMID:
29983236
PMCID:
PMC6286209
DOI:
10.1016/j.annepidem.2018.06.005
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center